Alexander Andrews1, Tesfaye Zelleke2, Dana Harrar2, Rima Izem3,4,5, Jiaxiang Gai3, Douglas Postels2,6. 1. Department of Pediatrics, MedStar Georgetown University Hospital, Washington, District of Columbia, U.S.A. 2. Department of Neurology, The George Washington University School of Medicine, Children's National Hospital, Washington, District of Columbia, U.S.A. 3. Division of Biostatistics and Study Methodology, Children's National Research Institute, Washington, District of Columbia, U.S.A. 4. Division of Epidemiology, The George Washington University School of Public Health, Washington, District of Columbia, U.S.A. 5. Department of Pediatrics, The George Washington University School of Medicine, Washington, District of Columbia, U.S.A. 6. Blantyre Malaria Project, University of Malawi College of Medicine, Blantyre, Malawi.
Abstract
PURPOSE: Pediatric cerebral malaria has high rates of mortality and neurologic morbidity. Although several biomarkers, including EEG, are associated with survival or morbidity, many are resource intensive or require skilled interpretation for clinical use. Automation of quantitative interpretation of EEG may be preferable in resource-limited settings, where trained interpreters are rare. As currently used quantitative EEG factors do not adequately describe the spectrum of variability seen in studies from children with cerebral malaria, the authors developed and validated a new quantitative EEG variable, theta-alpha variability (TAV). METHODS: The authors developed TAV, a new quantitative variable, as a composite of multiple automated EEG outputs. EEG records from 194 children (6 months to 14 years old) with cerebral malaria were analyzed. Independent EEG interpreters performed standard quantitative and qualitative analyses, with the addition of the newly created variable. The associations of TAV with other quantitative EEG factors, a qualitative assessment of variability, and outcomes were assessed. RESULTS: Theta-alpha variability was not highly correlated with alpha, theta, or delta power and was not associated with qualitative measures of variability. Children whose EEGs had higher values of TAV had a lower risk of death (odds ratio = 0.934, 95% confidence interval = 0.902-0.966) or neurologic sequelae (odds ratio = 0.960, 95% confidence interval = 0.932-0.990) compared with those with lower values. Receiver operating characteristic analysis in predicting death at a TAV threshold of 0.244 yielded a sensitivity of 74% and specificity of 70% for an area under the receiver operating characteristic curve of 0.755. CONCLUSIONS: Theta-alpha variability is independently associated with outcome in pediatric cerebral malaria and can predict death with high sensitivity and specificity. Automated determination of this newly created EEG factor holds promise as a potential method to increase the clinical utility of EEG in resource-limited settings by allowing interventions to be targeted to those at higher risk of death or disability. (C) 2021 by the American Clinical Neurophysiology Society.
PURPOSE: Pediatric cerebral malaria has high rates of mortality and neurologic morbidity. Although several biomarkers, including EEG, are associated with survival or morbidity, many are resource intensive or require skilled interpretation for clinical use. Automation of quantitative interpretation of EEG may be preferable in resource-limited settings, where trained interpreters are rare. As currently used quantitative EEG factors do not adequately describe the spectrum of variability seen in studies from children with cerebral malaria, the authors developed and validated a new quantitative EEG variable, theta-alpha variability (TAV). METHODS: The authors developed TAV, a new quantitative variable, as a composite of multiple automated EEG outputs. EEG records from 194 children (6 months to 14 years old) with cerebral malaria were analyzed. Independent EEG interpreters performed standard quantitative and qualitative analyses, with the addition of the newly created variable. The associations of TAV with other quantitative EEG factors, a qualitative assessment of variability, and outcomes were assessed. RESULTS: Theta-alpha variability was not highly correlated with alpha, theta, or delta power and was not associated with qualitative measures of variability. Children whose EEGs had higher values of TAV had a lower risk of death (odds ratio = 0.934, 95% confidence interval = 0.902-0.966) or neurologic sequelae (odds ratio = 0.960, 95% confidence interval = 0.932-0.990) compared with those with lower values. Receiver operating characteristic analysis in predicting death at a TAV threshold of 0.244 yielded a sensitivity of 74% and specificity of 70% for an area under the receiver operating characteristic curve of 0.755. CONCLUSIONS: Theta-alpha variability is independently associated with outcome in pediatric cerebral malaria and can predict death with high sensitivity and specificity. Automated determination of this newly created EEG factor holds promise as a potential method to increase the clinical utility of EEG in resource-limited settings by allowing interventions to be targeted to those at higher risk of death or disability. (C) 2021 by the American Clinical Neurophysiology Society.
Authors: Antti Tolonen; Mika O K Särkelä; Riikka S K Takala; Ari Katila; Janek Frantzén; Jussi P Posti; Markus Müller; Mark van Gils; Olli Tenovuo Journal: Clin EEG Neurosci Date: 2017-11-27 Impact factor: 1.843
Authors: Karl B Seydel; Samuel D Kampondeni; Clarissa Valim; Michael J Potchen; Danny A Milner; Francis W Muwalo; Gretchen L Birbeck; William G Bradley; Lindsay L Fox; Simon J Glover; Colleen A Hammond; Robert S Heyderman; Cowles A Chilingulo; Malcolm E Molyneux; Terrie E Taylor Journal: N Engl J Med Date: 2015-03-19 Impact factor: 91.245
Authors: Marjolein M Admiraal; Emily J Gilmore; Michel J A M Van Putten; Hitten P Zaveri; Lawrence J Hirsch; Nicolas Gaspard Journal: J Clin Neurophysiol Date: 2017-09 Impact factor: 2.177
Authors: Paul M Vespa; W John Boscardin; David A Hovda; David L McArthur; Marc R Nuwer; Neil A Martin; Valeriy Nenov; Thomas C Glenn; Marvin Bergsneider; Daniel F Kelly; Donald P Becker Journal: J Neurosurg Date: 2002-07 Impact factor: 5.115
Authors: Michael J Potchen; Gretchen L Birbeck; J Kevin Demarco; Sam D Kampondeni; Nicholas Beare; Malcolm E Molyneux; Terrie E Taylor Journal: Eur J Radiol Date: 2009-04-03 Impact factor: 3.528
Authors: Douglas G Postels; Chenxi Li; Gretchen L Birbeck; Terrie E Taylor; Karl B Seydel; Sam D Kampondeni; Simon J Glover; Michael J Potchen Journal: Am J Trop Med Hyg Date: 2014-09-08 Impact factor: 2.345
Authors: Jan Claassen; Lawrence J Hirsch; Kurt T Kreiter; Evelyn Y Du; E Sander Connolly; Ronald G Emerson; Stephan A Mayer Journal: Clin Neurophysiol Date: 2004-12 Impact factor: 3.708
Authors: Douglas G Postels; Xiaoting Wu; Chenxi Li; Peter W Kaplan; Karl B Seydel; Terrie E Taylor; Youssef A Kousa; Richard Idro; Robert Opoka; Chandy C John; Gretchen L Birbeck Journal: Malar J Date: 2018-05-22 Impact factor: 2.979
Authors: Alexander Andrews; Tesfaye Zelleke; Rima Izem; Jiaxiang Gai; Dana Harrar; Jessica Mvula; Douglas G Postels Journal: Pediatr Neurol Date: 2021-10-19 Impact factor: 3.372
Authors: Archana A Patel; Gretchen L Birbeck; Maitreyi Mazumdar; Suzanna Mwanza; Rosemary Nyirongo; Dixon Berejena; Joseph Kasolo; Tina Mwale; Violet Nambeye; Kafula Lisa Nkole; Nfwama Kawatu; Bo Zhang; Alexander Rotenberg Journal: BMJ Open Date: 2022-07-18 Impact factor: 3.006